BioCentury
ARTICLE | Financial News

Transkaryotic sells shoe

December 18, 2001 8:00 AM UTC

Transkaryotic (TKTX), a developer of protein therapeutics for rare genetic diseases, raised $16.4 million through the sale of 420,000 shares at $39 authorized to cover overallotments in its December f...